Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2013
|
| gptkbp:ATCCode |
N07XX09
|
| gptkbp:CASNumber |
624-49-7
|
| gptkbp:chemicalFormula |
C6H8O4
|
| gptkbp:eliminatedIn |
exhalation as CO2
|
| gptkbp:form |
capsule
|
| gptkbp:genericName |
gptkb:dimethyl_fumarate
|
| gptkbp:halfLife |
1 hour
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tecfidera
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Biogen
|
| gptkbp:mechanismOfAction |
immunotherapy
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescribes |
relapsing-remitting multiple sclerosis
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:lymphopenia
flushing gastrointestinal symptoms |
| gptkbp:synonym |
BG-12
|
| gptkbp:usedFor |
multiple sclerosis
|
| gptkbp:bfsParent |
gptkb:Biogen
|
| gptkbp:bfsLayer |
5
|